uvstocks.io

Today’s CSR movers

SRE 4.1 ▲ 1.2

ES 3.0 ▲ 0.8

EIX 3.1 ▲ 0.8

AMZN 4.7 ▲ 0.1

GS 2.3 ▼ 0.8

WEC 2.6 ▼ 1.2

ETR 2.9 ▼ 1.2

C 2.8 ▼ 1.2

PCG 2.9 ▼ 1.2

FOX 2.4 ▼ 1.5

Health Care · NASDAQ NASDAQ · ALGN

Align Technology

$175.05 -$1.70 -0.97% CLOSE 07.20.26 AFTER HOURS $175.05

Convergence score

4.0 / 5.0 STRONG BULLISH

+0.0 vs last report

Overall valuation

Fairly Valued

Aggregated across multiple horizons

Consensus target (12mo)

$208.07 +18.9%

Range $150.00 — $240.00

Sector

Health Care

NASDAQ · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 07.20.26

UV Convergence Score

REPORT 07.20.26

4.0

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Rating trend signal

4.2

Analyst average

4.2

Multi-signal aggregate How CSR works →

Day Range

$174.09 – $177.99

52W Range

$122.00 – $208.31

Volume

1.1M

Avg Vol

1.1M

Mkt Cap

$12.54B

P/E

29.42

EPS (TTM)

$5.95

Div Yield

—

Beta

1.67

Today's convergence

Convergence score sits at 4.0 with overall valuation reading as fairly valued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Fairly Valued

CSR direction

STRONG BULLISH

Last close

$175.05

Sector

Health Care

Valuation

Three horizons

UPDATED 07.20.26

Short term

0–3 MO

No target Moderate Buy

Medium term

3–12 MO

$206+17.7% Buy

Long term

12–36 MO

$184.61+5.5% Fairly Valued

Open valuation →

Analysts

Coverage & consensus

4 PANELS

Mean target (12mo)

$208.07 +18.9%

RANGE $150.00 — $240.00

Analyst consensus

Consensus rating Buy

Blended score 4.1 / 5

Analysts tracked 63

Open analysts →

Financials

Key metrics

LATEST

P/E

29.42

EPS (TTM)

$5.95

Mkt Cap

$12.54B

Div Yield

—

Beta

1.67

52W Range

$122.00 – $208.31

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26

Short term

0–3 MO

Moderate Buy

Consensus target

No target available

Current analyst consensus rating from Barchart.

Medium term

3–12 MO

Buy

Consensus target

$206 +17.7%

RANGE $150 – $240

$150NOW $175.05$240

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Fairly Valued

Consensus target

$184.61 +5.5%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 29.42	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $532.95M	PB Ratio: -	PS Ratio: -	Dividend: -

Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.1 4 63

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $150.00 $208.07 $210.00 $240.00 +18.9%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 4 17 10 0 1

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current Moderate Buy 4.19 16

1 Mo Ago Moderate Buy 4.27 15

2 Mo Ago Moderate Buy 4.13 15

3 Mo Ago Moderate Buy 4.13 15

Most recent analyst action LATEST DESK ACTION

Date

7/17/2026

Firm

Weiss Ratings

Action

Upgrade

Rating

Hold (C-) ➝ Hold (C)

Target

—

Full financial snapshot.

UPDATED 07.20.26

Quote snapshot 15 FIELDS

Prev Close

$176.76

Open

$177.08

Day Low

$174.09

Day High

$177.99

Bid

$161.03

Ask

$190.49

52W Low

$122.00

52W High

$208.31

50D Avg

$171.92

200D Avg

$164.55

Volume

1.1M

Avg Vol

1.1M

10D Avg Vol

847.0K

52W Change

-6.49%

S&P 52W Change

18.27%

Valuation ratios 10 FIELDS

P/E (TTM)

29.42

P/E (Fwd)

14.14

PEG (Fwd)

0.93

P/S

3.06

P/B

3.02

Book Value

$57.94

EV/Revenue

2.83

EV/EBITDA

13.16

Mkt Cap

12.54B

Enterprise Val

11.59B

Profitability & returns 6 FIELDS

Profit Margin

10.50%

Gross Margin

69.91%

Operating Margin

15.47%

EBITDA Margin

21.50%

Return on Assets

7.23%

Return on Equity

10.82%

Growth 3 FIELDS

Revenue Growth (YoY)

6.20%

Earnings Growth (YoY)

23.90%

Earnings Growth (Q)

21.00%

Balance sheet & cash flow 11 FIELDS

Total Revenue

4.1B

EBITDA

880.81M

Total Cash

1.06B

Total Debt

116.04M

Cash / Share

$14.80

Revenue / Share

$56.88

Free Cash Flow

532.95M

Operating CF

691.59M

Debt / Equity

2.80

Current Ratio

1.39

Quick Ratio

1.17

Dividend 5 FIELDS

Fwd Dividend

—

Dividend Yield

—

Payout Ratio

0.00%

5Y Avg Yield

—

Ex-Div Date

—

Share statistics 7 FIELDS

Shares Out

71.62M

Float

67.02M

Shares Short

4.68M

% Short of Float

7.46%

Short Ratio

4.39

% Held Insiders

6.82%

% Held Institutions

100.87%

Calendar & events 5 FIELDS

Next Earnings

2026-07-29

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-03-31

Last Split

—

Split Date

—

Company 2 FIELDS

Industry

Medical Instruments & Supplies

Employees

20,275